Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Owlet Baby Care offers a health monitor that allows parents to view their child's vital signs in real-time.
AtaiBeckley develops innovative mental health treatments that address significant unmet medical needs.
C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.
LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.
Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.
Biomea Fusion is a precision oncology company developing novel small molecules that target aggressive forms of cancer.
Xos Trucks specializes in the field of manufacturing fully electric commercial vehicles.
PepGen is empowering nucleic acid therapeutics to go the distance.
Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.
Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.
Galvanize is a biomedical platform company that provides therapeutic products and services to deliver healthcare solutions.
Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Heartflow is a medical technology company that provides various methods of diagnosis and treatment of cardiovascular disease.
Arbor Biotechnologies is a biotechnology company specializing in next-generation gene editing therapeutics to treat genetic diseases.
Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.
Bambusa Therapeutics operates as biotechnology company.
Aligos Therapeutics is discovering and developing new classes of molecules that interact directly with disease-causing modalities.
Ottimo Pharma develops innovative cancer therapies using PD1-VEGFR2 antibodies.
CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.
New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
nChroma Bio is a cutting-edge biotechnology business that is developing targeted in vivo delivery systems as well as best-in-class cargo.
Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.
35Pharma is a biopharmaceutical company that designs and develops innovative biologics for diseases of high unmet medical need.
Janus Henderson Investors has invested in 229 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Janus Henderson Investors's top investment sectors include Biotechnology, Health Care, Therapeutics, Life Science, Medical. The firm invests across 25 different industry categories.
Among tracked funding rounds, Avidity Biosciences received $690.0M in a Post-IPO Equity round. Janus Henderson Investors's total known invested capital is $34.7B.
Janus Henderson Investors's average investment size is $151.4M across its portfolio of 229 companies.
Recent Janus Henderson Investors portfolio additions include Owlet Baby Care, AtaiBeckley, C4 Therapeutics, LEXEO Therapeutics, Kailera Therapeutics. These companies were founded in 2020 or later.